15.03.2021 22:52:35
|
MorphoSys Swings To FY20 Profit
(RTTNews) - MorphoSys AG (MOR) reported full-year 2020 net profit of 97.9 million euros or 2.97 euro per share, compared to a loss of 103.0 million euros or 3.26 euros per share in the prior year.
Earnings before interest and taxes were 27.4 million euros, compared to a EBIT loss of 107.9 million euros in the previous year.
Group revenues were 327.7 million euros, up from 71.8 million euros in the prior year.
Monjuvi (tafasitamab-cxix) product sales totaled 18.5 million euros, while royalties on net sales of Tremfya amounted to 42.5 million euros.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Morphosys AG (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Morphosys AG (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Morphosys AG (spons. ADRs) | 16,70 | 3,73% |
|